Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

15.740
-0.160-1.01%
Volume:160.00K
Turnover:2.52M
Market Cap:25.59B
PE:7.41
High:15.990
Open:15.990
Low:15.680
Close:15.900
52wk High:19.716
52wk Low:14.000
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:0.64
T/O Rate:0.07%
Dividend:0.96
Dividend Rate:6.07%
EPS(LYR):2.123
ROE:7.43%
ROA:2.37%
PB:0.56
PE(LYR):7.41
PS:0.28

Loading ...

Baiyunshan Pharmaceutical Gets Macau Approval for Cefalexin Capsules

MT Newswires Live
·
Jul 21

Baiyunshan's Subsidiary Secures Macau Registration for Cefalexin Capsules

Stock News
·
Jul 20

Hong Kong Market Analysis: Capital Shifts from Tech to Biotech Amid Liquidity Drain and Sector Rotation

Stock News
·
Jul 10

Baiyunshan Reports Q1 2026 Revenue of 23.278 Billion Yuan, Up 3.58%

Deep News
·
Jul 10

Baiyunshan's Chen Jiehui Highlights Shift in Labor Demand: Decline in Traditional Workers, Surge in Innovative Talent

Deep News
·
Jun 23

Baiyunshan's Chen Jiehui: AI Technology Could Reduce New Drug Development Cycle to Five Years

Deep News
·
Jun 23

BAIYUNSHAN PH Subsidiary Obtains Drug Registration Certificate for Cefaclor Sustained-Release Tablets (II)

Stock News
·
Jun 10

Baiyunshan Pharma: May 2026 Monthly Return Shows Stable Share Capital, Full Public Float Compliance

Bulletin Express
·
Jun 02

Baiyunshan Pharmaceutical Gains China's Nod for Influenza Antiviral Suspension

MT Newswires Live
·
Jun 02

Key Corporate Updates from Hong Kong-Listed Firms: Drug Approvals, A-Share Plans, and May Sales Figures

Stock News
·
Jun 02

Baiyunshan Pharma Declares FY2025 Final Dividend of RMB 0.45 per Share; Payment Slated for 17 July 2026

Bulletin Express
·
May 29

BAIYUNSHAN PH to Distribute Final Dividend of HK$0.5162 per Share on July 17

Stock News
·
May 29

Guangzhou Baiyunshan Pharmaceutical Announces Updated Board Composition and Committee Structure

Bulletin Express
·
May 29

BAIYUNSHAN PH (00874) Appoints Chen Jiehui as Chairman and Legal Representative

Stock News
·
May 29

Baiyunshan's First Report Under Li Xiaojun Reveals Q4 Loss, Cash Shortfall Against Debt, and High Receivables

Deep News
·
May 26

BAIYUNSHAN PH (00874) Announces Completion of RMB 10 Billion Receivables Securitization by Guangzhou Pharmaceutical

Stock News
·
May 22

Guangzhou Baiyunshan Pharmaceutical - Letter Confirms Disposal of Initial Underlying Assets of Gp Corp. , Receipt of RMB1 Bln

THOMSON REUTERS
·
May 22

Guangzhou Baiyunshan Pharmaceutical - Gp Corp. Entered Into Completion Confirmation Letter With Industrial Securities Asset Management

THOMSON REUTERS
·
May 22

Baiyunshan (00874): Liu Hong Elected as Employee Representative Director for Tenth Board Term

Stock News
·
May 15

Baiyunshan Pharmaceutical Gets Supplementary Approvals for Two Drugs

MT Newswires Live
·
May 12